Findings identify a reproducible X-chromosome hypomethylation signature in female MS and support direct investigation of inactive-X regulation, XCI escape and X-linked immune gene dosage.
Abstract
Multiple sclerosis (MS) is approximately three times more common in females than in males, but sex-linked epigenetic mechanisms remain incompletely understood. We tested whether X-chromosome DNA methylation differs in females with MS and whether associated sites preferentially map to genes normally subject to X-chromosome inactivation (XCI). An X-chromosome-focused epigenome-wide association study was performed in whole blood from three datasets comprising 496 females with MS and 509 female controls, with independent evaluation in isolated CD4+ T cells (80 cases, 76 controls). At FDR < 0.01, 3 182 X-chromosome CpGs were hypomethylated in MS (mean {Delta}{beta} = -0.035). Hypomethylated CpGs were strongly enriched in non-escape genes normally subject to XCI relative to escape genes (OR 6.77; p = 1.55x10-57) and mapped to immune and chromatin-related processes. Exploratory cis-mQTL analysis identified strong local genetic effects at a small subset of loci, including WAS, IRAK1 and TLR7. In CD4+ T cells, 2 080 of the 3,182 whole-blood hypomethylated CpGs (65.4%) were also significantly hypomethylated. These findings identify a reproducible X-chromosome hypomethylation signature in female MS and support direct investigation of inactive-X regulation, XCI escape and X-linked immune gene dosage.
Cell-type-specific autism-associated differentially methylated positions (DMPs) are identified and a striking female-specific signature concentrated on the X chromosome in microglia is revealed, supporting the importance of microglia in autism and suggesting that altered X chromosome dosage regulation may contribute to...
Alice Franklin, Jonathan P. Davies, B. Chioza et al.· bioRxiv· 0 citations
Amyotrophic lateral sclerosis (ALS) shows well-established sex differences in incidence, age at onset and progression, but their biological basis is unclear. We hypothesised that the DNA methylation changes associated with ALS differ between the sexes, which would point to sex-specific disease processes. To test this,...
Young Jun Kim, A. Iacoangeli, R. Zwamborn et al.· bioRxiv· 0 citations
DNA methylation is a key epigenetic mechanism of sex chromosome regulation. However, DNA methylation studies often exclude X chromosomes. Moreover, widely used DNA methylation assays interrogate biased subsets of CpGs, rather than assessing CpGs across the whole chromosome. Consequently, our understanding of X ch...
Y. Loh, Robert Morgan, Devika Singh et al.· Epigenetics & Chromatin· 0 citations
MS-associated methylation changes enriched in the cohesin chromatin-regulation pathway localised to T-cell regulatory regions included multiple protocadherin (PCDH) genes, which displayed consistent methylation and expression changes in CSF cells of pwMS compared to controls.
Ya-Nan Han, G. Zheleznyakova, Heng Liang et al.· EBioMedicine· 0 citations
Preliminary evidence is provided that autosomal epigenetic remodeling and biological aging acceleration may contribute to phenotypic heterogeneity in AFD, and DunedinPACE may capture aspects of the cumulative systemic burden associated with pathogenic GLA variants.
M. A. Aceto, Ersilia Paparazzo, Gemma Antonucci et al.· Experimental Gerontology· 0 citations
Results support the view that ASE captures a broad regulatory signature in iPD, distinct from the DNA methylation context, and reinforces the role of immunogenetic dysregulation as a primary component of the disease's pathophysiology, offering new targets for mechanistic investigation and peripheral biomarkers.
R. M. Piergiorge, Alan Tardin da Silva, Ronaldo Francisco et al.· Computers in Biology and Med...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.